One of the goals of the National Action Plan is to accelerate development and use of rapid and innovative diagnostic tests for identification and characterization of resistant bacteria.

• A. Accelerate development and use of rapid and innovative diagnostic tests for identification and characterization of resistant bacteria.
• B. Focus solely on vaccine development.
• C. Limit international collaboration.
• D. Reduce surveillance.

Answer: (A)

The main idea tested is recognizing that a stated goal of the National Action Plan is to accelerate development and use of rapid diagnostic tests for identifying and characterizing resistant bacteria. Rapid diagnostics are essential because they quickly reveal whether a pathogen is drug-resistant, which guides clinicians to choose the most effective, targeted therapy and avoid unnecessary broad-spectrum antibiotics. This not only improves patient outcomes but also helps control the spread of resistance through timely infection prevention actions and informs surveillance efforts.

The other options don’t fit this specific objective. Focusing solely on vaccine development is important in public health but not the particular goal described here. Limiting international collaboration runs counter to the plan’s emphasis on sharing data and coordinating actions globally. Reducing surveillance would undermine the ability to detect and respond to resistance trends, whereas the plan aims to strengthen surveillance.